![image](https://github.com/user-attachments/assets/ed02e141-be17-4a7a-987e-daf2a9ebe796)---
layout: page
title: Na Jiao
position: Principle Investigator
image: /people/NaJiao.png
degree: Ph.D.
email: najiao@fudan,edu.cn
webside: https://jiaonall.github.io/
github: https://github.com/jiaonall
google_scholar: https://scholar.google.com/citations?user=aX4qqkIAAAAJ&hl=zh-CN&oi=ao
office: Fudan University, #2005 Songhu Road, Shanghai, China
introduce: <b>Na Jiao</b> is a young researcher with B.S. and Ph.D. in Bioinformatics from Tongji University. Now she is a Professor at the School of Life Sciences, Department of Microbiology and Immunology, Fudan University. Her research focuses on <b>Microbiota-Host Phyneotype</b>, <b>Microbiota-Host Interaction</b>,and <b>Microbiome Exploration and Mining</b>.
---
<style>
p {
    text-align: justify;
}
</style>

<h2>Na Jiao <small>Professor</small></h2>
<hr>

<div class='row'>
  <div class="col-lg-8">
    <p><b>Education:</b> Ph.D.</p>
    <p><b>Research areas:</b> Bioinformatics & Metagenomics </p>
    <p><b>Research focus:</b> Host-Microbiome Crosstalk, Heterogeneous (omics-)data integration, Biomarkers and Artificial intelligence</p>
  </div>
  <div class="col-lg-4">
    <div class="text-right">
        <img alt="najiao" src="/assets/img/people/NaJiao.png" width="200px" />
    </div>
  </div>
</div>

**Current position：**Distinguished research fellow (Professor), Children's Hospital of Zhejiang University School of Medicine

**More about me：**[焦娜-复旦大学个人主页](https://life.fudan.edu.cn/0f/e9/c31282a659433/page.htm)、[焦娜-同济CADD课题组个人主页](https://cadd.tongji.edu.cn/info/1053/1143.htm)

**Work Experience**

* Jan. 2024- Present: Young research fellow (professor level), School of Life Sciences, Department of Microbiology and Immunology, Fudan University

* Sep. 2021-Dec. 2023: Distinguished research fellow (Professor), National Clinical Research Center for Child Health, Children's Hospital of Zhejiang University School of Medicine

* Sep. 2019-Aug. 2021: Postdoctoral fellow, Bioinformatics, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

**Education**
* **Ph.D.**: Jun. 2019, Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai, China


* **B.S.**: Jun. 2014, Food Science and Engineering, College of Biological and Agricultural Engineering, Jilin University, Jilin, China

**Research Project**

1. National Natural Science Foundation of China, General Fund, 32470098, Mechanism for the gut microbiota-mediated bile acid metabolism promoting NAFLD pathogenesis via gut-liver axis, 2025-01 to 2028-12, 500000, in research，PI

2. National Natural Science Foundation of China, Young Scientists Fund, 82000536, Mechanism for the gut microbiota-mediated bile acid metabolism promoting NAFLD pathogenesis via gut-liver axis, 2021-01 to 2023-12, 240000, in research，PI

3. Higher Education Institutions Fundamental Research Project, Young Teachers Training Programs, 20ykpy07, Altered gut microbiome and mechanism in FUT2 loss-of-function mutants in inflammatory bowel disease, 2020-01to 2021-01, 120000, conclusion，PI

4. China Postdoctoral Science Foundation, General Program, 2019M663252, Role of the choline metabolizing microbiota in the pathogenesis of non-alcoholic fatty liver disease, 2020-01to 2021-08，80000, conclusion，PI

5. China Postdoctoral Science Foundation, Postdoctoral Innovative Talent Support Program, BX20190393, Identification of bile acid metabolizing bacteria and individualized intervention in the pathogenesis of nonalcoholic fatty liver disease, 2019-09 to 2021-08, 600000, conclusion，PI

**Publications**

1. Wenxing Gao<sup>#</sup>, Xiang Gaosup>#</sup>, Lixin Zhu<sup>\*</sup>, Sheng Gao, Ruicong Sun, Zhongsheng Feng, Dingfeng Wu, Zhanju Liu<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>, **Na Jiao**<sup>\*</sup>, Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer. **Gut Microbes**, *2023*; https://doi.org/10.1080/19490976.2023.2245562. 

1. Sheng Gao<sup>#</sup>, Xiang Gao<sup>#</sup>, Ruixin Zhu<sup>\*</sup>, Dingfeng Wu, Zhongsheng Feng, **Na Jiao**, Ruicong Sun, Wenxing Gao, Qing He<sup>\*</sup>, Zhanju Liu<sup>\*</sup>, Lixin Zhu<sup>\*</sup>. Microbial genes outperform species and SNVs as diagnostic markers for Crohn's disease on multicohort fecal metagenomes empowered by artificial intelligence. **Gut microbes**, *2023*, 15(1): 2221428.

1. Tingjun Xu<sup>#</sup>, Wenxing Gao<sup>#</sup>, Lixin Zhu<sup>\*</sup>, Wanning Chen, Chaoqun Niu, Wenjing Yin, Liangxiao Ma, Xinyue Zhu, Yunchao Ling, Sheng Gao, Lei Liu, **Na Jiao**, Weiming Chen, Guoqing Zhang<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>, and Dingfeng Wu<sup>\*</sup>. NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease. **J. Chem. Inf. Model**. **2023**; https://pubs.acs.org/doi/10.1021/acs.jcim.3c00395

1. Xiang Gao<sup>#</sup>, Ruicong Sun<sup>#</sup>, **Na Jiao**<sup>#</sup>, Xiao Liang, Gengfeng Li, Han Gao, Xiaohan Wu, Muqing Yang, Chunqiu Chen, Liang Chen, Wei Wu, Zhong Li, Yingzi Cong, Ruixin Zhu<sup>\*</sup>, Tiannan Guo<sup>\*</sup>, Zhanju Liu<sup>\*</sup>, Integrative multi-omics deciphers the spatial characteristics of host-gut microbiota interactions in Crohn’s disease. **Cell Reports Medicine**. *2023*; 4, 101050. 

1. Fengtao Cai<sup>#</sup>, Chenfen Zhou<sup>#</sup>, **Na Jiao**<sup>#</sup>, Xinling Liang, Zhiming Ye, Wei Chen, Qiongqiong Yang, Hui Peng, Ying Tang, Chaoqun Niu, Guoping Zhao, Zefeng Wang<sup>\*</sup>, Guoqing Zhang<sup>\*</sup>, Xueqing Yu<sup>\*</sup>. Systematic microbiome dysbiosis are associated with IgA nephropathy. **Microbiology Spectrum**. *2023*, e05202-22. 

1. Shaobo Zhao<sup>#</sup>, Kun Zhu<sup>#</sup>, Xiaoyi Li<sup>#</sup>, Xiaohui Zhong, Yanyan Zhao, Zhicong Liu, Yi Xiao, Dengming Lai, **Na Jiao**<sup>\*</sup>, Qiang Shu<sup>\*</sup>. Co-expression and interaction network analysis reveals dysregulated neutrophil and T-cell activation as the core mechanism associated with septic shock[J]. **Frontiers in Genetics**, *2023*, 14.
   
1. Dingfeng Wu<sup>#</sup>, Lei Liu<sup>#</sup>, **Na Jiao**<sup>#</sup>, Yida Zhang, Li Yang, Chuan Tian, Ping Lan, Lixin Zhu<sup>\*</sup>, Rohit Loomba<sup>\*</sup>, and Ruixin Zhu<sup>\*</sup>. Targeting Keystone Species Helps Restore the Dysbiosis of Butyrate-Producing Bacteria in Nonalcoholic Fatty Liver Disease. **iMeta**, *2022*; e61. https://doi.org/10.1002/imt2.61

1. Ningning Liu<sup>#</sup>, **Na Jiao**<sup>#</sup>, Jing-Cong Tan<sup>#</sup>, Ziliang Wang<sup>#</sup>, Dingfeng Wu, An-Jun Wang, Jie Chen, Liwen Tao, Chenfen Zhou, Wenjie Fang, Io Hong Cheong, Weihua Pan, Wanqing Liao, Zisis Kozlakidis, Christopher Heeschen, Geromy G. Moore, Lixin Zhu<sup>\*</sup>, Xingdong Chen<sup>\*</sup>, Guoqing Zhang<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>, Hui Wang<sup>\*</sup>. Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts. **Nature Microbiology**, *2022*; 7(2):238-250.
   
1. Sheng Gao, Yichen Li, Dingfeng Wu, **Na Jiao**, Li Yang, Rui Zhao, Zhifeng Xu, Wanning Chen, Xutao Lin, Sijing Cheng, Lixin Zhu<sup>\*</sup>, Ping Lan<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>. IBD subtype-regulators IFNG and GBP5 identified by causal inference drive more intense innate immunity and inflammatory responses in CD than those in UC. **Frontiers in Pharmacology**, *2022*, p.1049. 

1. Yuqi Wu<sup>#</sup>, **Na Jiao**<sup>#</sup>, Ruixin Zhu<sup>\*</sup>, Yida Zhang, Dingfeng Wu, An-Jun Wang, Sa Fang, Liwen Tao, Yichen Li, Sijing Cheng, Ping Lan, Chuan Tian<sup>\*</sup>, Ning-Ning Liu<sup>\*</sup>, Lixin Zhu<sup>\*</sup>. Identification of microbial markers across populations in early detection of colorectal cancer. **Nature Communications**, *2021*; 12(1):3063
   
1. **Na Jiao**<sup>#</sup>, Rohit Loomba<sup>#</sup><sup>\*</sup>, Zi-Huan Yang, Dingfeng Wu, Sa Fang, Richele Bettencourt, Ping Lan, Ruixin Zhu<sup>\*</sup>, Lixin Zhu<sup>\*</sup>. Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD. **Physiological Genomics**, *2021*; 53(8):336-348. 

1. Yichen Li<sup>#</sup>, Jie Li<sup>#</sup>, Jia Ke<sup>#</sup>, **Na Jiao**<sup>#</sup>, Lixin Zhu<sup>#</sup><sup>\*</sup>, Lihan Shen, Lei Chen, Zhiqiang Jiang, Sijing Cheng, Yibo Huang, Yifeng Zou, Ruixin Zhu<sup>\*</sup>, and Guangjun Yan<sup>\*</sup>. Adverse Outcomes Associated with Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study. **Frontiers of Medicine**, *2021*; 8: 604263.

1. Jingrong Weng<sup>#</sup>, Yichen Li<sup>#</sup>, Jie Li<sup>#</sup>, Lihan Shen<sup>#</sup>, Lixin Zhu<sup>#</sup><sup>\*</sup>, Yufan Liang, Xutao Lin, **Na Jiao**, Sijing Cheng, Yibo Huang, Yifeng Zou<sup>\*</sup>, Guangjun Yan<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>, Ping Lan<sup>\*</sup>. Gastrointestinal sequelae in patients after discharge for COVID-19. **The Lancet Gastroenterology & Hepatology**. *2021*, 6(5): 344-346.

1. Lu Zhao<sup>#</sup>, Wanning Chen<sup>#</sup>, Yongsheng Ge, Xin Lv, Ying Wang, Han Yu, Yi Liu, Dingfeng Wu, Na Jiao, Yuanqi Wu, Daqing Lv, Guoqing Zhang, Fuzhong Xue, Xiaohong Xu, Zhongtao Gai<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>, Lei Zhang<sup>\*</sup>, Guoping Zhao. Putative familial transmissible bacteria of various body niches link with home environment and children’s immune health. **Microbiology Spectrum**. *2021*, 9(3): e00872-21.

1. Yichen Li<sup>#</sup>, **Na Jiao**<sup>#</sup>, Lixin Zhu<sup>\*</sup>, Sijing Cheng, Ruixin Zhu<sup>\*</sup>; Ping Lan<sup>\*</sup>.Non-febrile COVID-19 patients were common and often became critically ill: a retrospective multicenter cohort study. **Critical Care**, *2020*; 24:314.

1. Sijing Cheng<sup>#</sup>, Dingfeng Wu<sup>#</sup>, Jie Li, Yifeng Zou, Yunle Wan, Lihan Shen, Lixin Zhu<sup>\*</sup>, Mang Shi, Linlin Hou, Tao Xu, **Na Jiao**, Yichen Li, Yibo Huang, Zhipeng Tang, Mingwei Xu, Shusong Jiang, Maokun Li<sup>\*</sup>, Guangjun Yan<sup>\*</sup>, Ping Lan<sup>\*</sup>, and Ruixin Zhu<sup>\*</sup>. Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study. **Respiratory Research**, **2020**; 21(1), 277. DOI: https://doi.org/10.1186/s12931-020-01492-zLu. 

1. Dingfeng Wu<sup>#</sup>, WenxingGao<sup>#</sup>, Xiaoyi Li<sup>#</sup>, Chuan Tian, **Na Jiao**, Sa Fang, Jing Xiao, Zhifeng Xu, Lixin Zhu<sup>\*</sup>, Guoqing Zhang<sup>\*</sup> and Ruixin Zhu<sup>\*</sup>. Dr AFC: Drug Repositioning Through Anti-Fibrosis Characteristic. **Briefings in Bioinformatics**, *2020*; 22(3). DOI: https://doi.org/10.1093/bib/bbaa115.

1. Yunle Wan<sup>#</sup>, Jie Li<sup>#</sup>, Lihan Shen<sup>#</sup>,Yifeng Zou<sup>#</sup>, Linlin Hou<sup>#</sup>, Lixin Zhu<sup>#,\*</sup>, Howard S.Faden, Zhipeng Tang, Mang Shi, **Na Jiao**, Yichen Li, Sijing Cheng, Yibo Huang, **Dingfeng Wu**, ZhifengXu, Linnuo Pan, Jun Zhu, GuangjunYan<sup>\*</sup>, Ruixin Zhu<sup>\*</sup>, and Ping Lan<sup>\*</sup>. Enteric involvement in hospitalised patients with COVID-19 outside Wuhan. **The Lancet Gastroenterology & Hepatology**, **2020**; 5(6), 534–535. DOI: https://doi.org/10.1016/S2468-1253(20)30118-7.

1. Sheng Gao<sup>#</sup>, Qian Zhang<sup>#</sup>, Chuan Tian, Chun Li, Yunzheng Lin, Wenxing Gao, Dingfeng Wu, **Na Jiao**, Lixin Zhu, Wenzhe Li, Ruixin Zhu<sup>\*</sup>, Wei Wang<sup>\*</sup>, Yong Wang<sup>\*</sup>. The roles of Qishen granules recipes, Qingre Jiedu, Wenyang Yiqi and Huo Xue, in the treatment of heart failure. **Journal of Ethnopharmacology**, *2020*; 249, 112372. 

1. Yali Zhang<sup>#</sup>, Liting Cai<sup>#</sup>, Junyi Qi, Yunzheng Lin, Yancheng Dai, **Na Jiao**, Youlan Chen, Lie Zheng, Beibei Wang, Lixin Zhu, Zhipeng Tang<sup>\*</sup>, and Ruixin Zhu. Gut Microbiota Contributes to the Distinction Between Two Traditional Chinese Medicine Syndromes of Ulcerative Colitis. **World Journal of Gastroenterology**, *2020*; 25(25), 3242. (IF=5.374)

1. **Na Jiao**, Susan S Baker<sup>\*</sup>, Adrian Chapa-Rodriguez, Wensheng Liu, Colleen A Nugent, Maria Tsompana, Lucy Mastrandrea, Michael J Buck, Robert D Baker, Robert J Genco, Ruixin Zhu<sup>\*</sup>, Lixin Zhu<sup>\*</sup>. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. **Gut**. *2018*; 67(10):1881-1891 
1. **Na Jiao**, Susan S. Baker, Colleen A. Nugent, Maria Tsompana, Liting Cai, Yong Wang, Michael J. Buck, Robert J. Genco, Robert D. Baker, Ruixin Zhu<sup>\*</sup>, Lixin Zhu<sup>\*</sup>. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis. **Physiological Genomics**. *2018*; 50(4):244-254. (**APSselect award** *https://www.physiology.org/toc/apsselect/5/4*) 

1. Xiaoyi Li<sup>#</sup>, , Hong Kang, Wensheng Liu, Sarita Singhal, Na Jiao, Yong Wang, Lixin Zhu, Ruixin Zhu<sup>\*</sup>. In silico Design of Novel Proton Pump Inhibitors with Reduced Adverse Effect. **Frontiers of Medicine**, *2018*; 13(2): 277-284. (IF=9.927)

1. Wei Xie<sup>#</sup><sup>\*</sup>, **Na Jiao**<sup>#</sup>, Cenling Ma, Sa Fang, Tommy J Phelps, Ruixin Zhu<sup>\*</sup>, Chuanlun Zhang. The response of archaeal species to seasonal variables in a subtropical aerated soil: insight into the low abundant methanogens. **Applied Microbiology and Biotechnology**, *2017*;101(16):6505-6515. 

1. Zhen Sheng<sup>#</sup>, Yi Sun, Ruixin Zhu, **Na Jiao**, Kailin Tang, Zhiwei Cao<sup>\*</sup>, Chao Ma<sup>\*</sup>. Functional Cross-Talking between Differentially Expressed and Alternatively Spliced Genes in Human Liver Cancer Cells Treated with Berberine. **PLoS ONE**, *2015*; 10(11): e0143742. 


**Academic Conference**

1. **Na Jiao**, Fusobacterium nucleatum, a reproducible microbial marker for CRC prescreening, Experimental Biology (EB 2021), Oral presentation. Online.

1. **Na Jiao**, Gut microbiota contributes to promoting secondary bile acid biosynthesis in NAFLD pathogenesis, Digestive Diseases Week (DDW 2019), Oral presentation. San Diego, CA.

1. **Na Jiao**, Suppressed hepatic bile acid signaling despite elevated production of primary and secondary bile acids in NAFLD, Digestive Diseases Week (DDW 2017), Oral presentation. Chicago, IL.

1. **Na Jiao**, Susan S. Baker, Colleen A. Nugent, Maria Tsompana, Liting Cai, Yong Wang, Michael J. Buck, Robert J. Genco, Robert D. Baker, Ruixin Zhu, Lixin Zhu, High-fat diet increases Clostridium clusters XIVa in obese rodents: a meta-analysis. Digestive Diseases Week (DDW 2017), Poster, Abstract #2674202, Chicago, IL.

1. Wei Xie, **Na Jiao**, Cenling Ma, Tommy. J. Phelps, Ruixin Zhu, Chuanlun Zhang, The Response of Archaeal Species to Seasonal Variables in a Subtropical Aerated Soil. Goldschmidt 2017, Poster, Abstract # gold2017: abs: 2017003171, Paris.

1. **Na Jiao**. Amplicon analysis and its application in disease. Symposium on Flora Analysis 2019. Oral presentation. Guangzhou, China


**Community Involvement**

1. **Frontiers in Microbiology** (IF=6.06). Review editor (2019-)

1. **Frontiers in Pharmacology** (IF=5.98). Review editor (2019-)
